|
1
|
O’Brien K, Cokkinides V, Jemal A, et al:
Cancer statistics for Hispanics, 2003. CA Cancer J Clin.
53:208–226. 2003.
|
|
2
|
Bruix J and Sherman M: Management of
hepatocellular carcinoma: an update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J, Raoul JL, Sherman M, et al:
Efficacy and safety of sorafenib in patients with advanced
hepatocellular carcinoma: subanalyses of a phase III trial. J
Hepatol. 57:821–829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Ricci S, Mazzaferro V, et al:
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med.
359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su M, Wu X, Chung HY, Li Y and Ye W:
Antiproliferative activities of five Chinese medicinal herbs and
active compounds in Elephantopus scaber. Nat Prod Commun.
4:1025–1030. 2009.PubMed/NCBI
|
|
6
|
Chang C, Zhu Y, Tang X and Tao W: The
anti-proliferative effects of norcantharidin on human HepG2 cells
in cell culture. Mol Biol Rep. 38:163–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee MK, Yeo H, Kim J, Markelonis GJ, Oh TH
and Kim YC: Cynandione A from Cynanchum wilfordii protects
cultured cortical neurons from toxicity induced by
H2O2, L-glutamate, and kainate. J Neurosci
Res. 59:259–264. 2000.
|
|
8
|
Lee MK, Yeo H, Kim J and Kim YC:
Protection of rat hepatocytes exposed to CCl4 in-vitro
by cynandione A, a biacetophenone from Cynanchum wilfordii.
J Pharm Pharmacol. 52:341–345. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng YR, Ding YF, Wei YJ, Shu B, Li YB and
Liu XD: Caudatin-2,6-dideoxy-3-O-methy-β-D-cymaropyranoside 1
induced apoptosis through caspase 3-dependent pathway in human
hepatoma cell line SMMC-7721. Phytother Res. 25:631–637. 2011.
|
|
10
|
Zhang JF, Li YB, Li CL and Jiang JQ:
Studies on chemical constituents in root tuber of Cynanchum
auriculatum. Zhongguo Zhong Yao Za Zhi. 31:814–816. 2006.(In
Chinese).
|
|
11
|
Pongracz JE and Stockley RA: Wnt
signalling in lung development and diseases. Respir Res. 7:152006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
MacDonald BT, Tamai K and He X:
Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev
Cell. 17:9–26. 2009.
|
|
13
|
Behari J: The Wnt/β-catenin signaling
pathway in liver biology and disease. Expert Rev Gastroenterol
Hepatol. 4:745–756. 2010.
|
|
14
|
El Wakil A and Lalli E: The
Wnt/beta-catenin pathway in adrenocortical development and cancer.
Mol Cell Endocrinol. 332:32–37. 2011.PubMed/NCBI
|
|
15
|
Monga SP: Role of Wnt/β-catenin signaling
in liver metabolism and cancer. Int J Biochem Cell Biol.
43:1021–1029. 2011.
|
|
16
|
Xiong F, Leonov S, Howard AC, et al:
Receptor for advanced glycation end products (RAGE) prevents
endothelial cell membrane resealing and regulates F-actin
remodeling in a β-catenin-dependent manner. J Biol Chem.
286:35061–35070. 2011.PubMed/NCBI
|
|
17
|
Goodwin AM and D’Amore PA: Wnt signaling
in the vasculature. Angiogenesis. 5:1–9. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mei JM, Borchert GL, Donald SP and Phang
JM: Matrix metalloproteinase(s) mediate(s) NO-induced dissociation
of β-catenin from membrane bound E-cadherin and formation of
nuclear beta-catenin/LEF-1 complex. Carcinogenesis. 23:2119–2122.
2002.PubMed/NCBI
|
|
19
|
Arii S, Mise M, Harada T, et al:
Overexpression of matrix metalloproteinase 9 gene in hepatocellular
carcinoma with invasive potential. Hepatology. 24:316–322. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kamel L, Nessim I, Abd-el-Hady A, Ghali A
and Ismail A: Assessment of the clinical significance of serum
vascular endothelial growth factor and matrix metalloproteinase-9
in patients with hepatocellular carcinoma. J Egypt Soc Parasitol.
35:875–890. 2005.
|
|
21
|
Zhang X, Gaspard JP and Chung DC:
Regulation of vascular endothelial growth factor by the Wnt and
K-ras pathways in colonic neoplasia. Cancer Res. 61:6050–6054.
2001.PubMed/NCBI
|
|
22
|
Baryawno N, Sveinbjornsson B, Eksborg S,
Chen CS, Kogner P and Johnsen JI: Small-molecule inhibitors of
phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/β-catenin
pathway cross-talk and suppress medulloblastoma growth. Cancer Res.
70:266–276. 2010.PubMed/NCBI
|
|
23
|
Tung JN, Chiang CC, Tsai YY, et al:
CyclinD1 protein expressed in pterygia is associated with β-catenin
protein localization. Mol Vis. 16:2733–2738. 2010.PubMed/NCBI
|
|
24
|
Zhang JY, Tao LY, Liang YJ, et al:
Secalonic acid D induced leukemia cell apoptosis and cell cycle
arrest of G(1) with involvement of GSK-3β/β-catenin/c-Myc pathway.
Cell Cycle. 8:2444–2450. 2009.PubMed/NCBI
|
